跳至主要内容
临床试验/EUCTR2005-003599-39-DE
EUCTR2005-003599-39-DE进行中(未招募)1 期

A randomized, double-blind, placebo-controlled, comparative trial of AMD3100 (240 mcg/kg) plus G-CSF (10 mcg/kg) versus G-CSF (10 mcg/kg) plus placebo to mobilize and collect greater than or equal to 6x10e6 CD34+ cells/kg in multiple myeloma patients for autologous transplantation - N/A

AnorMED Corp.0 个研究点目标入组 10 人开始时间: 2005年9月13日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • *Diagnosis of multiple myeloma in first or second complete or partial remission
  • *ECOG performance status of 0 or 1
  • *White Blood Cell count (WBC) > 2.5 x 10e9/L
  • *Platelet (PLT) > 100 x 10e9/L
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • *Failed previous stem cell collection
  • *Previous stem cell transplantation
  • *Brain metastases or myelomatous meningitis
  • *Radiation to pelvis
  • *History of ventricular arrhythmias

研究者

发起方
AnorMED Corp.

相似试验

A randomized, double-blind, placebo-controlled,... | 临床试验